Volume 26, Number 11—November 2020
Research
High Dengue Burden and Circulation of 4 Virus Serotypes among Children with Undifferentiated Fever, Kenya, 2014–2017
Table 2
Characteristic | Participants with dengue viremia, n = 361 | Participants without dengue viremia, n = 661 | p value |
---|---|---|---|
Mean (SD) age, y | 5.2 (3.4) | 5.6 (3.9) | 0.13 |
Mean (SD) temperature, °C | 38.8 (0.6) | 38.9 (0.7) | 0.14 |
Mean (SD) no. illness days before seeking care |
2.8 (1.6) |
2.7 (1.5) |
0.21 |
Sex | |||
F | 168 (46.5) | 299 (45.2) | 0.74 |
M |
193 (53.5) |
362 (54.8) |
0.74 |
Signs and symptoms | |||
Headache | 179 (49.6) | 326 (49.3) | 0.99 |
Poor appetite | 169 (46.8) | 240 (36.3) | 0.001 |
Cough | 165 (45.7) | 278 (42.1) | 0.29 |
Joint pain | 133 (36.8) | 259 (39.2) | 0.50 |
Nausea or vomiting | 128 (35.5) | 219 (33.1) | 0.50 |
Chills | 66 (18.3) | 118 (17.9) | 0.93 |
Abdominal pain | 46 (12.7) | 134 (20.3) | 0.003 |
Diarrhea | 42 (11.6) | 68 (10.3) | 0.58 |
Muscle aches |
30 (8.3) |
54 (8.2) |
1.00 |
Malaria smear positive | 150 (51.5) | 291 (52.3) | 0.88 |
DENV IgG present at febrile visit | 14 (4.0) | 12 (1.9) | 0.07 |
Prescribed antimicrobial drugs | 182 (50.4) | 290 (43.9) | 0.05 |
Prescribed antimalarial drugs | 176 (48.8) | 243 (36.8) | <0.001 |
*Values are no. (%) unless indicated otherwise. DENV, dengue virus.
Page created: August 06, 2020
Page updated: October 17, 2020
Page reviewed: October 17, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.